How important is glycemic control during coronary artery bypass? (Q34370678)

1 August 2017

How important is glycemic control during coronary artery bypass? (English)

1 reference

coronary artery bypass surgery

1 August 2017

1 reference

Harold L Lazar

1

1 reference

1 August 2017

1 January 2012

1 reference

1 August 2017

1 reference

1 August 2017

46

1 reference

1 August 2017

219-235

1 reference

Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Impact of hyperglycemia on perioperative mortality after coronary artery bypass graft surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Clinical and economic impact of diabetes following coronary artery bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Expression of inducible nitric oxide synthase in conduits used in patients with diabetes mellitus undergoing coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Comparison of endothelium-dependent vasoactivity of internal mammary arteries from hypertensive, hypercholesterolemic, and diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Thromboxane biosynthesis and platelet function in type II diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Insulin attenuates the systemic inflammatory response in endotoxemic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Value of postoperative blood glucose in predicting complications and length of stay after coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Impact of admission serum glucose level on in-hospital outcomes following coronary artery bypass grafting surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Limiting ischemic myocardial damage using glucose-insulin-potassium solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Glucose control lowers the risk of wound infection in diabetics after open heart operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Continuous insulin infusion reduces infectious complications in diabetics following coronary surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Intensive insulin therapy in critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Attempted control of hyperglycemia during cardiopulmonary bypass fails to improve neurologic or neurobehavioral outcomes in patients without diabetes mellitus undergoing coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Intensive versus conventional glucose control in critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Clinical experience with tight glucose control by intensive insulin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Effects of intensive glucose lowering in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Severe hypoglycemia and risks of vascular events and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2012.03.007

10.1016/J.YASU.2012.03.007

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

22873042